Engineering living therapeutics—particularly engineered probiotics and synbiotics—represents one of the boldest frontiers in modern biopharma, and success in this field depends on choosing the right probiotic and synbiotic CDMO. Unlike traditional biologics that are static molecules, these are living medicines: microbes designed to colonize, adapt, and actively participate in human health. At their core lies […]
Exosomes have gone from obscure cellular curiosities to the most hyped therapeutic modality of the decade. These extracellular vesicles (EVs) — nanosized packages of RNA, proteins, and lipids secreted by nearly every cell type — are nature’s built-in communication system. They carry messages between cells, reprogram distant tissues, and orchestrate complex biological responses. If mRNA […]
As bacteriophages transition from research tools to real-world therapeutics and biocontrol solutions, the role of the phage CDMO (Contract Development and Manufacturing Organization) has become pivotal. Unlike standard biologics such as monoclonal antibodies or recombinant proteins, phages are living biological entities with unique life cycles, host dependencies, and manufacturing constraints. Scaling their production requires expertise […]
As the demand for next-generation natural products, precision biosynthesis, and novel antibiotics rises, the limitations of conventional microbial hosts become more apparent. While E. coli and Bacillus excel in protein expression, they fall short in handling large, complex biosynthetic gene clusters (BGCs) or producing high-value secondary metabolites. Enter Streptomyces coelicolor—a soil-dwelling actinomycete with extraordinary genetic […]
As the biologics landscape diversifies beyond monoclonal antibodies and traditional expression systems, there is increasing demand for alternative microbial hosts that combine scalability, safety, and process efficiency. While Escherichia coli and CHO cells dominate much of the contract development and manufacturing ecosystem, Bacillus—particularly Bacillus subtilis, Bacillus licheniformis, and Bacillus megaterium—has re-emerged as a strategic microbial […]
As demand for recombinant proteins, enzymes, and biologics continues to rise across therapeutics, diagnostics, and synthetic biology, bacterial expression systems—especially E. coli—remain foundational to biomanufacturing. But choosing the right bacterial CDMO (Contract Development and Manufacturing Organization) isn’t just about price or batch size—it’s about deep expertise, flexible infrastructure, and scientific alignment. Here are the 10 […]
Introduction: Why E. coli Still Reigns in Biologics Manufacturing Despite the rise of mRNA, mammalian cell lines, and synthetic biology tools, Escherichia coli remains one of the most widely used hosts in biologics development and manufacturing. Its fast doubling time, well-characterized genetics, and cost-effective scalability make it the preferred choice for producing recombinant proteins, enzymes, […]
In the rapidly evolving world of biotechnology, microbial CDMOs (Contract Development and Manufacturing Organizations) play a pivotal role in transforming lab-scale discoveries into real-world therapeutic, industrial, and diagnostic products. For companies seeking speed, flexibility, and scalability in microbial fermentation, Elise Biopharma stands apart as the premier microbial CDMO partner. With a foundation built on three […]
In a world where a single FDA draft guidance can upend your project plan, you need more than headlines—you need voices that educate, provoke, inspire, and sometimes entertain. These ten blogs each bring their own perspective: some break stories faster than press releases, others deconstruct complex science with clarity, and a few even turn regulatory […]
Introduction In the symphony of biotechnology, fermentation serves as both composer and conductor, orchestrating the elegant dance of microorganisms as they synthesize proteins with precision and abundance. I think of fermentation not merely as a method but as a living tapestry—threads of microbial metabolism woven into a fabric of biochemical ingenuity. Through controlled environments and […]
In biomanufacturing, Escherichia coli (E. coli) has become the microbial engine behind everything from diagnostics and biologics to alternative proteins. Its growth kinetics, low cost, and genetic pliability make it an industry favorite. But the next-generation CDMO must be more than just a fermentation service provider—it must be an agile, automated, green innovation partner. This […]
Bioinformatics has emerged as a pivotal force in modern biology, bridging the gap between raw data and actionable insights. By integrating computational algorithms with vast biological datasets, this discipline is revolutionizing pathogen detection, disease surveillance, and drug development. Below, we explore several cutting-edge approaches and technical breakthroughs that illustrate how bioinformatics is decoding life at […]
Contract Development and Manufacturing Organizations (CDMOs) specializing in fermentation and biomolecule production face complex contamination risks that can jeopardize batch integrity, regulatory compliance, and product efficacy. While spore-forming bacteria (sporocidal challenges) are a common concern, contamination risks extend beyond microbial spores. These risks, if not managed properly, can lead to costly product recalls, compromised drug […]
Antibody-drug conjugates (ADCs) represent a significant advancement in precision oncology, merging the targeted specificity of monoclonal antibodies with the potent cytotoxic effects of chemotherapy agents. ADCs selectively deliver powerful therapeutic payloads directly to cancer cells, theoretically minimizing systemic toxicity and improving clinical outcomes. Despite their promise, the clinical development of ADCs faces critical challenges, including […]
Gene therapy, once a futuristic dream, is swiftly becoming a clinical reality, driven by breakthroughs in Adeno-associated virus (AAV) vector technologies. AAV vectors are now at the forefront of biomedical innovation, enabling targeted and effective delivery of therapeutic genes. This article explores recent advancements in AAV vector production, optimization, and their critical role in addressing […]
Tangential Flow Filtration (TFF) is a sophisticated filtration method used extensively in the biopharmaceutical industry for the concentration, desalting, and purification of biomolecules. Unlike conventional filtration techniques where the feed flows perpendicularly through the filter, TFF processes fluid tangentially across the surface of the membrane. This approach minimizes the accumulation of retained species on the […]
Recombinant protein production is a pivotal component of biotechnology, playing a crucial role in the development of new pharmaceuticals, agricultural enhancements, and industrial biocatalysts. This extensive guide delves deeper into the processes, key technologies, and major players in the field, providing a thorough overview for professionals and enthusiasts alike. 1. Introduction to Recombinant Proteins Recombinant […]
As we delve into the recent innovations at the intersection of artificial intelligence (AI) and biopharmaceutical data analysis, it is evident that the synergy between these fields is not merely additive but transformative. The application of AI in biopharma encompasses a range of complex, data-intensive challenges, from drug discovery and development to predictive modeling and […]
The fungi strain fermentation market has witnessed substantial innovation in recent years, driven by the increasing demand for sustainable and efficient biotechnological solutions across various industries. These advancements have not only enhanced the yield and efficiency of fungal fermentation processes but also broadened the application spectrum in pharmaceuticals, agriculture, and biofuel production. Here, we explore […]
Antibodies, monoclonal antibodies, Fab fragments, bispecific/trispecific antibodies, and antibody-drug conjugates (ADCs) represent pivotal innovations in immunology and biotechnology, each offering unique characteristics and specialized applications across various medical and research fields. This comprehensive overview delineates their structures, mechanisms, and roles in advancing healthcare and scientific understanding. 1. Antibodies (Immunoglobulins) Structure and Production: Antibodies are large, […]
